Serious doubts on safety and efficacy of CCR5 antagonists : CCR5 antagonists teeter on a knife-edge

Infection. 2006 Apr;34(2):110-3. doi: 10.1007/s15010-006-6206-1.
No abstract available

Publication types

  • Review

MeSH terms

  • Benzoates / adverse effects
  • Benzoates / therapeutic use
  • CCR5 Receptor Antagonists*
  • Clinical Trials as Topic
  • Clinical Trials, Phase II as Topic
  • Cyclohexanes / adverse effects
  • Cyclohexanes / therapeutic use
  • Diketopiperazines
  • HIV Fusion Inhibitors / adverse effects*
  • HIV Fusion Inhibitors / therapeutic use*
  • HIV Infections / drug therapy*
  • HIV-1 / drug effects
  • Humans
  • Maraviroc
  • Piperazines / adverse effects
  • Piperazines / therapeutic use
  • Pyrimidines / adverse effects
  • Pyrimidines / therapeutic use
  • Spiro Compounds / adverse effects
  • Spiro Compounds / therapeutic use
  • Treatment Outcome
  • Triazoles / adverse effects
  • Triazoles / therapeutic use

Substances

  • Benzoates
  • CCR5 Receptor Antagonists
  • Cyclohexanes
  • Diketopiperazines
  • HIV Fusion Inhibitors
  • Piperazines
  • Pyrimidines
  • Spiro Compounds
  • Triazoles
  • aplaviroc
  • Maraviroc
  • vicriviroc